2877 Stock Overview
An investment holding company, engages in the research and development, manufacture, and trade of Chinese medicines in the People’s Republic of China and Hong Kong. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
China Shineway Pharmaceutical Group Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$8.28 |
| 52 Week High | HK$10.72 |
| 52 Week Low | HK$6.61 |
| Beta | 0.81 |
| 11 Month Change | -16.28% |
| 3 Month Change | 0.24% |
| 1 Year Change | 17.28% |
| 33 Year Change | 14.36% |
| 5 Year Change | 3.50% |
| Change since IPO | 71.61% |
Recent News & Updates
Recent updates
China Shineway Pharmaceutical Group Limited's (HKG:2877) Price Is Right But Growth Is Lacking After Shares Rocket 27%
Oct 18
If EPS Growth Is Important To You, China Shineway Pharmaceutical Group (HKG:2877) Presents An Opportunity
Jun 03Is China Shineway Pharmaceutical Group (HKG:2877) A Risky Investment?
May 13China Shineway Pharmaceutical Group (HKG:2877) Has Announced That It Will Be Increasing Its Dividend To CN¥0.461
Apr 26Are Investors Undervaluing China Shineway Pharmaceutical Group Limited (HKG:2877) By 41%?
Apr 17China Shineway Pharmaceutical Group (HKG:2877) Is Increasing Its Dividend To CN¥0.461
Mar 31China Shineway Pharmaceutical Group Limited's (HKG:2877) 26% Price Boost Is Out Of Tune With Earnings
Mar 14Does China Shineway Pharmaceutical Group (HKG:2877) Deserve A Spot On Your Watchlist?
Jan 29China Shineway Pharmaceutical Group (HKG:2877) Seems To Use Debt Rather Sparingly
Sep 28China Shineway Pharmaceutical Group (HKG:2877) Is Paying Out A Dividend Of CN¥0.118
Sep 01We Ran A Stock Scan For Earnings Growth And China Shineway Pharmaceutical Group (HKG:2877) Passed With Ease
Aug 03Are Investors Undervaluing China Shineway Pharmaceutical Group Limited (HKG:2877) By 44%?
May 30We Ran A Stock Scan For Earnings Growth And China Shineway Pharmaceutical Group (HKG:2877) Passed With Ease
Mar 07China Shineway Pharmaceutical Group's (HKG:2877) Dividend Will Be Reduced To CN¥0.125
Sep 01China Shineway Pharmaceutical Group Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Mar 31China Shineway Pharmaceutical Group (HKG:2877) Has A Rock Solid Balance Sheet
Apr 07China Shineway Pharmaceutical Group's(HKG:2877) Share Price Is Down 55% Over The Past Three Years.
Mar 11Should You Buy China Shineway Pharmaceutical Group Limited (HKG:2877) For Its Dividend?
Feb 18
Should You Use China Shineway Pharmaceutical Group's (HKG:2877) Statutory Earnings To Analyse It?
Jan 31Is China Shineway Pharmaceutical Group Limited (HKG:2877) Trading At A 49% Discount?
Jan 13What Is The Ownership Structure Like For China Shineway Pharmaceutical Group Limited (HKG:2877)?
Dec 25We Think China Shineway Pharmaceutical Group (HKG:2877) Can Manage Its Debt With Ease
Dec 10Reflecting on China Shineway Pharmaceutical Group's (HKG:2877) Share Price Returns Over The Last Five Years
Nov 25Shareholder Returns
| 2877 | HK Pharmaceuticals | HK Market | |
|---|---|---|---|
| 7D | -5.9% | -2.0% | -2.7% |
| 1Y | 17.3% | -9.4% | 10.9% |
Return vs Industry: 2877 exceeded the Hong Kong Pharmaceuticals industry which returned -8.3% over the past year.
Return vs Market: 2877 exceeded the Hong Kong Market which returned 11.3% over the past year.
Price Volatility
| 2877 volatility | |
|---|---|
| 2877 Average Weekly Movement | 5.2% |
| Pharmaceuticals Industry Average Movement | 6.9% |
| Market Average Movement | 9.0% |
| 10% most volatile stocks in HK Market | 19.0% |
| 10% least volatile stocks in HK Market | 4.2% |
Stable Share Price: 2877 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 2877's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | 3,232 | n/a | www.shineway.com |
China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese medicines in the People’s Republic of China and Hong Kong. The company offers Chinese medicines in the form of injection, soft capsules, and granules; tablets, pills, oral liquid, and powder; and traditional Chinese medicine granules in various therapeutic areas, including respiratory system disease, nervous system, digestive system disease, cardiovascular and cerebrovascular, orthopedics, pediatrics, and other areas, as well as medication for strengthening the body. It is also involved in the trading of agricultural products; and research and development of Chinese pharmaceutical products.
China Shineway Pharmaceutical Group Limited Fundamentals Summary
| 2877 fundamental statistics | |
|---|---|
| Market cap | HK$6.25b |
| Earnings (TTM) | HK$1.19b |
| Revenue (TTM) | HK$4.53b |
5.3x
P/E Ratio1.4x
P/S RatioIs 2877 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2877 income statement (TTM) | |
|---|---|
| Revenue | CN¥4.20b |
| Cost of Revenue | CN¥1.04b |
| Gross Profit | CN¥3.16b |
| Other Expenses | CN¥2.06b |
| Earnings | CN¥1.10b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.46 |
| Gross Margin | 75.21% |
| Net Profit Margin | 26.27% |
| Debt/Equity Ratio | 4.5% |
How did 2877 perform over the long term?
See historical performance and comparison